More Information on 'Adroit DI Ltd'

Adroit DI, also known as "One Platform for Molecules, Targets & Reactions", is a company that provides a unified data platform called Discoverant, which integrates chemistry and biology data in a single schema. The platform allows users to manage, search, and deliver insights from their scientific data, including small molecules, biologics, proteins, and reactions. Discoverant offers features such as industrial-grade structure search, stereochemistry handling, and reaction database management, as well as tools for protein registration, target management, and assay data analysis. The platform can be deployed on-premises, in the cloud, or in a hybrid environment, and is designed to be scalable and secure, with options for white-labeling and custom integration. Adroit DI's services include discovery engagements, custom consulting, and platform deployment, with a focus on serving the needs of biotech, pharma, and research institutions.

About Adroit DI Ltd
Structuring scientific data for future AI At Adroit DI, we assist scientific organizations in organizing their data to pave the way for future advancements in artificial intelligence. Our objective is to establish order and structure in complex scientific data, enabling it to fuel the next generation of innovations through AI. Our software solutions are built on a pre-clinical chemistry toolkit that has served as the foundation for our rapidly growing platform. Our customers benefit from our expertise in tackling challenges related to chemistry data searching, chirality, mixtures, and comprehensive filtering. As we expand, we are focusing on handling more biological data and providing insights into regulated clinical information. Adroit DI is headquartered in Shoreditch, London, with subsidiaries in the U.S. and a global presence. Our interdisciplinary team brings together decades of experience across life sciences, healthcare IT, data science, and AI engineering. We firmly believe that structured data holds the key to unlocking the potential of AI to transform scientific research and discovery. Therefore, we are continually investing in expanding our platform to extract more value from our customers' crucial data assets.